Nature of Disclosure: Regulatory filing to BSE Limited regarding upcoming board meeting for financial results approval.
Board Meeting Details: The meeting of the Board of Directors will be held on Friday, November 13, 2026 to consider and approve the Unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026.
Regulatory Compliance: The disclosure is made pursuant to Regulations 29 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Trading Window Closure: As previously communicated on September 28, 2026, the trading window for dealing in securities of the Company has been closed from October 01, 2026 and will remain closed until 48 hours after the declaration of financial results, specifically up to Sunday, November 15, 2026 (both days inclusive).
Company Information: CIN: L51900MH1985PLC036946. Registered address: A-201, 2nd Floor, Navneelam Premises CHS., 108, DR R G Thadani Marg, Podar Hospital, Worli, Mumbai City, Maharashtra, 400018. Contact: Emgl1234@rediffmail.com, Tel: 9167346889.
Financial Impact: The actual financial results and their impact will be determined and disclosed after the board meeting on November 13, 2026.